Save on Brilinta with Coupons, Discounts & Savings Programs

Brilinta is the brand name for ticagrelor and is available as an oral tablet.

Brilinta is available as a 60 mg and 90 mg oral tablet.

Brilinta is an antiplatelet that is used for heart attack and stroke prevention.

Brilinta is an antiplatelet medication. When you bleed, blood cells called platelets help form clots to help stop the bleeding. However, clots can be dangerous if they form in your blood vessels since they can block blood flow, which can lead to a heart attack or stroke. By preventing your platelets from sticking together and forming dangerous blood clots, it lowers your risk of heart attack or stroke.

Brilinta is typically dosed as follows:

• To reduce the risk of heart attack and stroke in people who’ve had a previous heart attack: The typical dose of Brilinta (ticagrelor) is a one-time dose of 180 mg by mouth on day 1, then 90 mg by mouth twice daily for the first year. After the first year, take 60 mg by mouth twice daily
• To reduce the risk of first-time heart attack or stroke in high-risk people with coronary artery disease (CAD): The typical dose is 60 mg by mouth twice daily
• To reduce the risk of stroke in people with a history of stroke: The typical dose is a one-time dose of 180 mg by mouth on day 1, then 90 mg by mouth twice daily for up to 30 days

Brilinta is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication in the following:

• History of intracranial hemorrhage Active pathological bleeding
• Hypersensitivity to ticagrelor or any component of the product

Common side effects of Brilinta:

• Shortness of breath
• Bleeding
• Nausea
• Diarrhea
• Dizziness
• Slow heart rate

Serious side effects are rare with Brilinta. Contact your healthcare provider immediately if you experience any of the following.

• Severe bleeding that doesn’t stop
• Pink, red, or brown urine (these could be signs of bleeding)
• Vomiting or coughing up blood
• Swelling of the mouth, tongue, and throat

The following medications may interact with Brilinta:

• Avoid use with strong CYP3A inhibitors or CYP3A inducers
• Patients receiving more than 40 mg per day of simvastatin or lovastatin may be at increased risk of statin-related adverse effects
• Monitor digoxin levels with initiation of or any change in Brilinta

AstraZeneca

It is not known if Brilinta will harm your unborn baby. You and your doctor should decide if you will take Brilinta.

• Ticagrelor